Advances in the intraoperative delineation of malignant glioma margin

Shan Jiang1, Huihui Chai1, Qisheng Tang1

  • 1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.

Frontiers in Oncology
|February 13, 2023
PubMed

Insights

Accurately identifying malignant glioma margins during surgery is challenging. This study reviews four intraoperative technologies—magnetic resonance imaging, fluorescence-guided surgery, Raman histology, and mass spectrometry—to improve tumor margin delineation for better patient outcomes.

Area of Science:

  • Neurosurgery
  • Oncology
  • Medical Technology

Background:

  • Malignant glioma surgery is critical but hampered by infiltrative growth and brain shift.
  • Distinguishing tumor margins visually or preoperatively is difficult for neurosurgeons.
  • Precise intraoperative margin delineation is essential for effective glioma treatment.

Purpose of the Study:

  • To review and compare four intraoperative technologies for delineating malignant glioma margins.
  • To analyze the principles, development, advantages, and disadvantages of each technology.
  • To project future trends in intraoperative glioma margin detection.

Main Methods:

  • Review of magnetic resonance imaging (MRI) for intraoperative guidance.
  • Analysis of fluorescence-guided surgery (FGS) techniques.
  • Evaluation of Raman histology for real-time tissue analysis.
  • Assessment of mass spectrometry (MS) for molecular profiling at the tumor margin.

Main Results:

  • Each technology offers unique capabilities for margin detection.
  • MRI provides anatomical context, while FGS enhances visualization.
  • Raman histology and MS offer molecular-level insights into tumor boundaries.
  • Comparative analysis highlights the strengths and limitations of each approach.

Conclusions:

  • Advanced intraoperative technologies significantly improve the ability to delineate malignant glioma margins.
  • Combining different technologies may offer synergistic benefits for precision surgery.
  • Continued technological development is crucial for advancing glioma treatment and patient survival.

Related Concept Videos